Baxter buy stake in Sigma IV pump

Intravenous products: Forbes.com report ‘Baxter International Inc. said Wednesday it bought a stake in Sigma International and will market one of the company’s infusion pumps, paying $100 million upfront in the deal.

Baxter will buy a 40 percent stake in Sigma of Medina, N.Y., and could pay an additional $130 million if the Spectrum pumps reach development, regulatory and commercial milestones, or buy the company outright. The deal is not expected to have a significant impact on Baxter’s results this year”.

Click here for the full story on Forbes.com

More IV news at IVTEAM

Other stories

• Infection prevention video
• Infusion pump malfunction
• Needlefree blood test
• Recognition and treatment of anaphylaxis
• 40 percent recapped needles
• IVTEAM launch poster page
• Thromboembolism CVC risk
• World Congress on Vascular Access
• Heparin label confusion
• Neonatal central line management
• Virtual IV station
• Patient dies after IV drug error

Add IVTEAM to Technorati Favorites